Cardiac transplantation: the final therapeutic option for the treatment of heart failure
- 1 May 2000
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 15 (3) , 178-182
- https://doi.org/10.1097/00001573-200005000-00010
Abstract
End-stage heart failure is still associated with a decrease in quality and prognosis of life. Cardiac transplantation remains the final extraordinary therapeutic option for the treatment of truly irreversible end-stage heart failure in all age groups. The selection process of candidates and the acceptance of patients with relative contra-indications is characterized by the experience and skills of an interdisciplinary transplant team, which should have access to different mechanical circulatory support systems for short-term or long-term use: bridging to transplant as well as for recovery.Keywords
This publication has 27 references indexed in Scilit:
- Six-year experience of caring for forty-four patients with a left ventricular assist device at home: Safe, economical, necessaryThe Journal of Thoracic and Cardiovascular Surgery, 2000
- Influence of Different Assist Devices on Survival after Orthotopic Heart TransplantationThe International Journal of Artificial Organs, 1999
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Permanent ventricular assist device support versus cardiac transplantationThe Annals of Thoracic Surgery, 1999
- The registry of the international society for heart and lung transplantation: sixteenth official report—1999The Journal of Heart and Lung Transplantation, 1999
- An analysis of the effect of age on survival after heart transplantThe Journal of Heart and Lung Transplantation, 1999
- Mortality remains high for outpatient transplant candidates with prolonged (>6 months) waiting list timeJournal of the American College of Cardiology, 1999
- Heart Transplantation in Patients 70 Years of Age and Older: Initial ExperienceThe Annals of Thoracic Surgery, 1996
- Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.Circulation, 1994
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987